|
| 1
|
|
||
| 11-19
|
html
|
|
|
| 21-29
|
html
|
Gene
expression profiles related with overcoming cisplatin resistance in human
cancer cell lines Moonkyu
Kim, Young Jin Park, Ok Ju Kim, Gab Yong Lee, Eun Jung Chung, Young Kwan
Sung, Jung Chul Kim, Insook Han, Youn Soo Sohn
|
|
| 31-37
|
html
|
Vascular
endothelial growth factor modulates cisplatin sensitivity in human ovarian
carcinoma cells Research Article
|
|
| 39-46 |
html | Overexpression
of angiogenic growth factors in lung cancer cells is associated with cisplatin
resistance
|
|
| 47-61 | html | Cisplatin
nephrotoxicity: molecular mechanisms
|
|
| 63-70 | Mitoxantrone, prednisone, pentostatin and bleomycin for patients with indolent non-Hodgkin’s lymphoma relapsed or unresponsive to previous treatments. Results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi (GISL) Research Article
|
||
| 71-79 | html | Chemotherapy
in elderly patients with advanced breast cancer
|
|
| 81-92 | html | Drug
resistance in breast cancer
|
|
93-102 |
Screening
for lung cancer: a review and current status
|
||
| 103-107 | html | Expression
of RB1CC1, a novel tumor suppressor gene, is inversely correlated with
the Ki-67 proliferation index in primary breast cancers
|
|
| 109-120 | html |
Approaches
to the treatment of brain tumors using cytokine-secreting allogeneic fibroblasts
|
|
121-131 |
html | Safety,
feasibility and clinical benefit of localized chemotherapy using microencapsulated
cells for inoperable pancreatic carcinoma in a phase I/II trial
Research
Article
|
|
| 133-142 | html |
Electrochemotherapy:
advantages and drawbacks in treatment of cancer patients
|
|
| 143-151 | html | p16
downregulates VEGF and inhibits angiogenesis in breast cancer cells
|
|
| 153-162 | html |
Basic
fibroblast growth factor antisense oligonucleotides inhibit renal cell
carcinoma cell growth and angiogenesis
|
|
| 163-171 | html |
Antitumoral cell-based therapies
Javier García-Castro, Daniel Rubio, Ricardo de la Fuente, Antonio Bernad
|
|
| 173-178 | html |
Can
mortalin be a candidate target for cancer therapy?
|
|
| 179-190 | html |
Therapeutic
potential of antinuclear autoantibodies in cancer
|
|
| 191-196 | html |
Filgrastim use: evaluation in cancer and critically ill non- cancer patients Research Article Yolande B. Saab, Leyla Sharaf, Ismail Zeidan
|
|
| 197-202 | html | Gemcitabine, cisplatin, fluorouracil and folinic acid as first line treatment of locally advanced and/or metastatic pancreatic cancer: a phase II study of the gruppo oncologico dell’Italia meridionale (G.O.I.M.) Research Article Vittorio Gebbia, Francesco Giuliani, Generoso Uomo, Evaristo Maiello, Maria Rosaria Valerio, Nicolo Borsellino, Nicolò Gebbia4 and Giuseppe Colucci
|
|
| 203-208 | html | Phase I study of high dose 5-fluorouracil and folinic acid in weekly continuous infusions Research Article
|
|
| 209-213 | html | High-dose methotrexate with citrovorum factor for malignant fibrous histiocytoma of soft tissue: a cell culture study Research
Article
|
|
| 215-221 | html | Phase
II intergroup trial of sequential chemotherapy and radiotherapy for AIDS-related
primary central nervous system lymphoma Research
Article |
|
| 223-232 | html | Sentinel
lymph node biopsy for breast cancer: addressing the controversies Anees Chagpar, John Pilavas, Celia Chao, Robert C.G. Martin II, Kelly M. McMasters
|
|
| 233-236 | html | A
randomised, double-blind, phase II study of three different marimastat
schedules administered to patients with resected Dukes C colorectal cancer
|
|
| 237-244 | html | LY900003: A novel compound for the treatment of non-small cell lung cancer
Susannah E. Motl
|
|
| 145-256 | html |
Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis
Berghmans T, Lafitte JJ, Mascaux C, Meert AP1, Paesmans M2 and Sculier JP |
|
| 257-262 | html | Expression of insulin-like growth factors and their receptors in malignant fibrous histiocytoma of soft tissues
Tetsuji Yamamoto , Toshihiro Akisue, Tetsuya Nakatani, Takashi Marui, Ikuo Fujita, Keiji Matsumoto, Toshiaki Hitora, Teruya Kawamoto, Keiko Nagira, Masahiro Kurosaka |
|
| 263-268 | html | Ethical, cultural and religious aspects of hereditary cancer in Jewish communities
Mark Levin
|
|
| 269-273 | html | Selective intraarterial cisplatin chemotherapy in treatment of advanced malignant squamous cell carcinoma of the head and neck
Afshin Teymoortash*, Jochen A. Werner
|
|
| 275-281 | html | Protein kinase C-delta and its downstream effectors as potential targets for cancer therapy
Jihua Liu, David Durrant and Ray M. Lee* Huntsman Cancer Institute and Section of Oncology, Department of Internal Medicine, University of Utah, 2000 Circle of Hope, Salt Lake City, UT, 84112
|
|
| 283-291 | html | A Phase I safety and imaging study using radiofrequency ablation (RFA) followed by 131I-chTNT-1/B radioimmunotherapy adjuvant treatment of hepatic metastases
Peter M. Anderson1,2,3*, Gregory A. Wiseman3,4, Bradley D. Lewis5, J. William Charboneau5, William L. Dunn4, Susan P. Carpenter6, Terrence Chew6
|
|
| 293-298 | html | Allelic loss at the SEP15 locus in breast cancer
Mohamed A. Nasr, Ya Jun Hu, and Alan M. Diamond*
|
|
| 299-314 | html | Dendritic cell based vaccines for immunotherapy of cancer
Asim Saha, Sunil K. Chatterjee, Kartik Mohanty, Kenneth A. Foon1, Malaya Bhattacharya-Chatterjee*
|
|
| 315-322 | html | Multitargeted antifolate (Pemetrexed): A comprehensive review of its mechanisms of action, recent results and future prospects
Delphine Exinger1, Françoise Exinger2, Bertrand Mennecier3, Jean-Marc Limacher1, Patrick Dufour1, Jean-Emmanuel Kurtz 1,2,*
|
|
| 323-333 | html | Molecular therapy of gastric cancer
Jie Chen1, Minhu Chen2, Christoph Röcken 3, Tobias Götze1, Peter Malfertheiner1 and Matthias P.A. Ebert1
|
|
| 335-342 | html | Tumor angiogenesis as a strategy for radiosensitization
Bo Lu, Dong W. Kim, Dennis E. Hallahan1,3*
|
|
| 343-351 | html | p14 ARF: Role in the cellular stress response and applications to cancer
Yinghui Huang and Ruth A. Gjerset Sidney Kimmel Cancer Center, 10835 Altman Row, San Diego, CA 92121
|
|
| 353-362 | html | The role of B lymphocytes in breast cancer: a review and current status
Sazini Nzula 1*, James J. Going 2, David I. Stott 1
|
|
| 363-371 | html | Advances in breast cancer therapy and chemoprevention: current strategies and new approaches
Brittney-Shea Herbert Department of Medical and Molecular Genetics and The Indiana University Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA
|
|
| 373-391 | html | Treatment planning in endometrial cancer
Angiolo Gadducci, Stefania Cosio, Andrea Riccardo Genazzani
|
|
| 393-405 | html | Dendritic cell-mediated immunosuppression in malignant melanoma Marta E Polak, Nicola J Borthwick, Martine J Jager, Ian A Cree
|